Full Name | Brenda Boyko |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 33 Years |
Location | 810 S. Main St., Moscow, Idaho |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184775124 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | RPT-1512 (Idaho) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bk Inc. | 6406948090 | 8 |
News Archive
Gottlieb Memorial Hospital is welcoming members of the community, local dignitaries and invited guests as it recognizes the 50th anniversary of its founding. A public celebration will be held at 2 p.m. on Friday, Nov. 4, in the hospital's newly renovated lobby, where cake will be served.
Research indicated that some Indigenous people such as in Alaska and Australia displayed limited immunity response to the effects of influenza.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, today announced that it has successfully completed two Phase 1a clinical studies for AVL-292, its orally-available, selective inhibitor of Bruton's tyrosine kinase (Btk).
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that they have completed enrollment of a phase II clinical trial of brentuximab vedotin (SGN-35) for relapsed or refractory systemic anaplastic large cell lymphoma.
› Verified 3 days ago
Provider Name | Bk Inc. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1659429405 PECOS PAC ID: 6406948090 Enrollment ID: O20070828000276 |
News Archive
Gottlieb Memorial Hospital is welcoming members of the community, local dignitaries and invited guests as it recognizes the 50th anniversary of its founding. A public celebration will be held at 2 p.m. on Friday, Nov. 4, in the hospital's newly renovated lobby, where cake will be served.
Research indicated that some Indigenous people such as in Alaska and Australia displayed limited immunity response to the effects of influenza.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, today announced that it has successfully completed two Phase 1a clinical studies for AVL-292, its orally-available, selective inhibitor of Bruton's tyrosine kinase (Btk).
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that they have completed enrollment of a phase II clinical trial of brentuximab vedotin (SGN-35) for relapsed or refractory systemic anaplastic large cell lymphoma.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Brenda Boyko, PT 1055 Presby Rd, Viola, ID 83872-9767 Ph: (208) 882-3839 | Brenda Boyko, PT 810 S. Main St., Moscow, ID 83843 Ph: (208) 883-1522 |
News Archive
Gottlieb Memorial Hospital is welcoming members of the community, local dignitaries and invited guests as it recognizes the 50th anniversary of its founding. A public celebration will be held at 2 p.m. on Friday, Nov. 4, in the hospital's newly renovated lobby, where cake will be served.
Research indicated that some Indigenous people such as in Alaska and Australia displayed limited immunity response to the effects of influenza.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, today announced that it has successfully completed two Phase 1a clinical studies for AVL-292, its orally-available, selective inhibitor of Bruton's tyrosine kinase (Btk).
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that they have completed enrollment of a phase II clinical trial of brentuximab vedotin (SGN-35) for relapsed or refractory systemic anaplastic large cell lymphoma.
› Verified 3 days ago
Hilary Eleanor Snell, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 872 Troy Rd, Suite 180, Moscow, ID 83843 Phone: 208-882-1426 | |
Ms. Susan M Rounds, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 317 W 6th, #206 Sage & Cedar Pt, Moscow, ID 83843 Phone: 208-882-4041 | |
Douglas Patrick Lynch, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2118 Lexington Avenue, Moscow, ID 83843 Phone: 801-834-1792 | |
Glenda Dorman Thie, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 872 Troy Highway, Suite 180, Moscow, ID 83843 Phone: 208-882-1426 | |
Mr. Douglas A Houle, MSPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2009 S Main St, Moscow, ID 83843 Phone: 208-882-1426 | |
Dr. Kristen Topliff, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 700 S Main St, Moscow, ID 83843 Phone: 208-883-6547 Fax: 208-883-6452 |